 Sorrento Therapeutics Inc NASDAQ: SRNE announced the publication of a preprint entitled Chimeric mRNA based COVID-19 vaccine induces protective immunity against Omicron and Delta. Serum collected from omicron-specific mRNA vaccine immunized animals provided superior. 